カテゴリ： , , MarketLine

Alexion Pharmaceuticals, Inc.

◆英語タイトル：Alexion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY3503
◆発行会社（調査会社）：MarketLine
◆発行日：2019
◆ページ数：54
◆レポート言語：
◆レポート形式：PDF
◆納品方法：E
◆対象地域：
◆産業分野：Pharmaceuticals and Healthcare
◆販売価格オプション（消費税別）
Single UserUSD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site LicenseUSD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide LicenseUSD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Alexion Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Alexion Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

Alexion Pharmaceuticals, Inc. (Alexion or ‘the company’) is a biopharmaceutical company involved in the innovation, development and commercialization of life-transforming therapeutic products. The company focuses on the therapeutic areas such as Hematology, Neurology, Nephrology and Metabolic disorders.Its product portfolio comprises Soliris (eculizumab) for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG); Strensiq (asfotase alfa) for the treatment of patients with hypophosphatasia; and Kanuma (sebelipase alfa) for the treatment of patients with lysosomal acid lipase deficiency. The company primarily operates in the US, Europe and Asia-Pacific. It is headquartered in New Haven, Connecticut, the US.

Scope

- Detailed information on Alexion Pharmaceuticals, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Alexion Pharmaceuticals, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Alexion Pharmaceuticals, Inc. including a breakdown and examination of key business segments
- Intelligence on Alexion Pharmaceuticals, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Alexion Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Alexion Pharmaceuticals, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Alexion Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Alexion Pharmaceuticals, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Alexion Pharmaceuticals, Inc.: Company Overview
Alexion Pharmaceuticals, Inc.: Overview and Key Facts
Alexion Pharmaceuticals, Inc.: Overview
Alexion Pharmaceuticals, Inc.: Key Facts
Alexion Pharmaceuticals, Inc.: Key Employees
Alexion Pharmaceuticals, Inc.: Key Employee Biographies
Alexion Pharmaceuticals, Inc.: Major Products and Services
Alexion Pharmaceuticals, Inc.: Company History
Alexion Pharmaceuticals, Inc.: Management Statement
Alexion Pharmaceuticals, Inc.: Locations and Subsidiaries
Alexion Pharmaceuticals, Inc.: Key Competitors
Alexion Pharmaceuticals, Inc.: Company Analysis
Alexion Pharmaceuticals, Inc.: Business Description
Alexion Pharmaceuticals, Inc.: SWOT Analysis
Alexion Pharmaceuticals, Inc.: SWOT Overview
Alexion Pharmaceuticals, Inc.: Strengths
Alexion Pharmaceuticals, Inc.: Weaknesses
Alexion Pharmaceuticals, Inc.: Opportunities
Alexion Pharmaceuticals, Inc.: Threats
Alexion Pharmaceuticals, Inc.: Corporate Financial Deals Activity
Alexion Pharmaceuticals, Inc.: Financial Deals Overview
Alexion Pharmaceuticals, Inc.: Targets and Partners
Alexion Pharmaceuticals, Inc.: Top Deals 2015 – 2019YTD*
Alexion Pharmaceuticals, Inc.: Advisors
Alexion Pharmaceuticals, Inc.: Top Legal Advisors
Alexion Pharmaceuticals, Inc.: Top Financial Advisors
Alexion Pharmaceuticals, Inc.: Mergers and Acquisitions
Alexion Pharmaceuticals, Inc.: Partnership
Alexion Pharmaceuticals, Inc.: Divestments
Alexion Pharmaceuticals, Inc.: Recent Developments
Alexion Pharmaceuticals, Inc.: News and Events Summary
Alexion Pharmaceuticals, Inc.: Contracts
Alexion Pharmaceuticals, Inc.: Corporate Governance
Alexion Pharmaceuticals, Inc.: Financial Deals
Alexion Pharmaceuticals, Inc.: Red Flags/DistressSignals
Alexion Pharmaceuticals, Inc.: Regulatory and Legal Events
Alexion Pharmaceuticals, Inc.: Research & Development
Alexion Pharmaceuticals, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Alexion Pharmaceuticals, Inc.: Key Facts
Table 2: Alexion Pharmaceuticals, Inc.: Key Employees
Table 3: Alexion Pharmaceuticals, Inc.: Company History
Table 4: Alexion Pharmaceuticals, Inc.: Locations and Subsidiaries
Table 5: Alexion Pharmaceuticals, Inc.: Key Competitors
Table 6: Alexion Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Alexion Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 8: Alexion Pharmaceuticals, Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Alexion Pharmaceuticals, Inc.: Targets and Partners
Table 10: Alexion Pharmaceuticals, Inc.: Top Deals 2015 - 2019YTD*
Table 11: Alexion Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: Alexion Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: Alexion Pharmaceuticals, Inc.: M&A Volume and Value Trend (2015 - YTD*2019)
Table 14: Alexion Pharmaceuticals, Inc.: M&A Activity by Geography (2015 - YTD*2019)
Table 15: Alexion Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2015 - YTD*2019)
Table 16: Alexion Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2015 - YTD*2019)
Table 17: Alexion Pharmaceuticals, Inc.: Divestments Volume and Value Trend (2015 - YTD*2019)
Table 18: Alexion Pharmaceuticals, Inc.: News and Events Summary
Table 19: Alexion Pharmaceuticals, Inc.: Contracts
Table 20: Alexion Pharmaceuticals, Inc.: Corporate Governance
Table 21: Alexion Pharmaceuticals, Inc.: Financial Deals
Table 22: Alexion Pharmaceuticals, Inc.: Red Flags/DistressSignals
Table 23: Alexion Pharmaceuticals, Inc.: Regulatory and Legal Events
Table 24: Alexion Pharmaceuticals, Inc.: Research & Development
Table 25: Alexion Pharmaceuticals, Inc.: Strategy and Operations

★海外企業調査レポート[Alexion Pharmaceuticals, Inc.]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Fresh Del Monte Produce Inc (FDP)：企業の財務・戦略的SWOT分析
    Fresh Del Monte Produce Inc (FDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Otsuka Pharmaceutical Co Ltd-製薬・医療分野：企業M&A・提携分析
    Summary Otsuka Pharmaceutical Co Ltd (OPC), a subsidiary of Otsuka Holdings Co Ltd is a provider of healthcare products. The company offers products which include pocari sweat, pocari sweat ion water, oronamin c, calorie mate, nature made, jerubure, jarinea, five mini, amino-value, enerugen, jog mat …
  • Indiana Municipal Power Agency-エネルギー分野：企業M&A・提携分析
    Summary Indiana Municipal Power Agency (IMPA) is a not-for-profit wholesale power provider supplying power to cities and communities across Indiana and Ohio. The agency was formed by its member utilities which enable them to share power resources and provide electricity economically to their custome …
  • BioCat GmbH-医療機器分野：企業M&A・提携分析
    Summary BioCat GmbH (BioCat) is a medical device company that markets innovative products and services for life science research. The company provides products such as antibodies, epigenetics, PCR, cloning, viral systems, tissue-specific analysis, reporter assays, diabetes, fluorescent proteins, sam …
  • Zimplats Holdings Ltd：企業の戦略・SWOT・財務分析
    Zimplats Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Zimplats Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Puget Energy, Inc.：企業の戦略・SWOT・財務情報
    Puget Energy, Inc. - Strategy, SWOT and Corporate Finance Report Summary Puget Energy, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Curis Inc (CRIS)：製薬・医療：M&Aディール及び事業提携情報
    Summary Curis Inc (Curis) is a biotechnology company that focuses on developing and commercializing novel drug candidates for treating human cancers with substantial unmet medical need. It has three drug candidates in development, CUDC-907 for diffuse large B-cell lymphoma (DLBCL) and solid tumors; …
  • Scynexis Inc (SCYX)：企業の財務・戦略的SWOT分析
    Summary Scynexis Inc (Scynexis) is a pharmaceutical company that discovers, develops and commercializes novel anti-infective for various therapeutic needs. The company provides pipeline products such as SCY-078, is used for invasive fungal infections; SCY-635, is used for the treatment of Hepatitis …
  • Fred’s, Inc.：戦略・SWOT・企業財務分析
    Fred's, Inc. - Strategy, SWOT and Corporate Finance Report Summary Fred's, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Toma Biosciences Inc-製薬・医療分野：企業M&A・提携分析
    Summary Toma Biosciences Inc (Toma Biosciences) is a biotechnology company that provides genome sequencing solutions. The company launched TOMA OS-Seq cancer assay to laboratories and researchers for the changes in tumors. Its products include reagent kits developed to detect genomic changes in canc …
  • Aura Energy Ltd (AEE)：企業の財務・戦略的SWOT分析
    Summary Aura Energy Ltd (Aura Energy) is a mining and mineral exploration and development company. The company’s business activities include acquisition, exploration, and development of uranium properties in Europe and Africa. Its projects comprise Haggan Uranium Project, Kallsedet Uranium Project, …
  • PT Supreme Cable Manufacturing & Commerce Tbk (SCCO)：企業の財務・戦略的SWOT分析
    PT Supreme Cable Manufacturing & Commerce Tbk (SCCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s k …
  • Japan Logistics Fund, Inc. ：企業の戦略・SWOT・財務情報
    Japan Logistics Fund, Inc. - Strategy, SWOT and Corporate Finance Report Summary Japan Logistics Fund, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Advance Syntex Ltd：企業の戦略的SWOT分析
    Advance Syntex Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Bank of Singapore Ltd.：企業の戦略・SWOT・財務情報
    Bank of Singapore Ltd. - Strategy, SWOT and Corporate Finance Report Summary Bank of Singapore Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Danubius Hotel And Spa Private Company Limited：企業の戦略・SWOT・財務分析
    Danubius Hotel And Spa Private Company Limited - Strategy, SWOT and Corporate Finance Report Summary Danubius Hotel And Spa Private Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Glenmark Pharmaceuticals Ltd (GLENMARK)：企業の財務・戦略的SWOT分析
    Glenmark Pharmaceuticals Ltd (GLENMARK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Star Phoenix Group Ltd (STA)：企業の財務・戦略的SWOT分析
    Star Phoenix Group Ltd (STA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • IOOF Holdings Ltd (IFL)：企業の財務・戦略的SWOT分析
    IOOF Holdings Ltd (IFL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • mAbxience SA：製薬・医療：M&Aディール及び事業提携情報
    Summary Mabxience SA (mAbxience), a subsidiary of Chemo Espana SA, is a biotechnology company that research, develops and manufactures biosimilar monoclonal antibodies. The company develops biosimilars, which are used for the treatment and prevention of various diseases in onclology such as breast c …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆